• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Ultra-processed foods linked to increased risk of type 2 diabetes

byJames EnglandandAnees Daud
January 2, 2020
in Chronic Disease, Endocrinology, Gastroenterology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this prospective cohort study from France, consumption of ultra-processed foods (UPF) was linked to an increased risk of type 2 diabetes (T2D).

2. The association between UPF and T2D remained significant after accounting for other metabolic comorbidities and weight change.

Evidence Rating Level: 2 (Good)           

Study Rundown: Dietary content has a profound influence on the development of many medical conditions including metabolic disorders, cardiovascular disease, and malignancies. The increased dietary intake of ultra-processed foods (UPF) has been previously linked to an increased risk of all-cause mortality, cancer, dyslipidemia, obesity, and hypertension. The current study sought to evaluate the risk of T2D associated with consumption of UPF in a large, modern prospective cohort. The study found that increased intake of UPF, by both total intake per day and percentage of total diet, was linked to an increased risk of T2D. The association was significant even after adjusting for metabolic comorbidities and weight change.

The current study highlights another potential harm associated with a diet high in UPF. The exact components and processing steps un UFP that may explain this association are not known. The strength of the study is the large, modern prospective cohort with repeated dietary intake data available for each study participant. The main limitations of the study include the potential for under diagnosis of T2D in the general population, the large variety of UPF, and the inability to evaluate causal relationships between specific UPF products and components.

Click to read the study in JAMA Internal Medicine

RELATED REPORTS

Tirzepatide-associated improvements in cardiometabolic risk factors linked to degree of weight loss

Semaglutide may improve cardiovascular outcomes versus empagliflozin in patients with diabetes

#VisualAbstract: Once-Weekly Mazdutide Reduced Body Weight in Obese or Overweight Chinese Adults

Relevant Reading: Comparing Different Policy Scenarios to Reduce the Consumption of Ultra-Processed Foods in UK: Impact on Cardiovascular Disease Mortality Using a Modelling Approach

In-Depth [prospective cohort]: This study is a prospective cohort study using data from the NutriNet-Santé study cohort, an ongoing web-based population from France that launched in 2009. Participants were included if they were 18-years or older, and completed 3 nonconsecutive web-based 24hr dietary records at baseline and every six months. Health questionnaires were filled out every three months and T2D was either self-reported or inferred from medication use. Participants were excluded if they had not completed follow-up surveys. Food processing degree was categorized based on the NOVA classification.

A total of 104 707 participants with a median (SD) baseline age of 42.7 (14.5) years were included in this study. The risk of T2D was 166 per 100,000 patient years in the greatest consumers of UPF foods compared to 113 per 100,000 patient years in the lowest consumers. Risk of T2D was increased with increasing UPF consumption (hazard ratio [HR] per 10 percentage point increment in dietary intake of 1.15 (95%CI, 1.06-1.25). This associated risk remained significant after adjusting for metabolic comorbidities (HR, 1.13; 95%CI, 1.03-1.23), and weight change (HR, 1.13; 95%CI, 1.01-1.27).

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: metabolic syndromeNutriNet-Santé studyobesityType 2 Diabetes Mellitusultra-processed foods (UPF)
Previous Post

Typhoid vaccine Phase 3 trial in Nepal

Next Post

#VisualAbstract: Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent

RelatedReports

Sleep duration inversely related to childhood type 2 diabetes risk makers
Cardiology

Tirzepatide-associated improvements in cardiometabolic risk factors linked to degree of weight loss

June 23, 2025
Compliance-linked incentives increase infant immunizations rates in rural India
Endocrinology

Semaglutide may improve cardiovascular outcomes versus empagliflozin in patients with diabetes

June 16, 2025
#VisualAbstract: Once-Weekly Mazdutide Reduced Body Weight in Obese or Overweight Chinese Adults
StudyGraphics

#VisualAbstract: Once-Weekly Mazdutide Reduced Body Weight in Obese or Overweight Chinese Adults

June 16, 2025
Increased number of daily steps linked with decreased mortality in older women
Chronic Disease

Semaglutide improves walking ability in patients with peripheral artery disease and type 2 diabetes

May 29, 2025
Next Post
#VisualAbstract: Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent

#VisualAbstract: Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent

Placebo formulation impacts effectiveness of pain control in osteoarthritis

MIV-711 effective in reducing bone and cartilage manifestations for patients with osteoarthritis

#VisualAbstract: Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants

#VisualAbstract: Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Sodium-glucose cotransporter 2 inhibitors may decrease risk of serious liver events in patients with cirrhosis
  • #VisualAbstract: Lactated Ringer’s Solution Does Not Improve Outcomes Relative to Normal Saline
  • 2MM: AI Roundup – FDA’s AI Push, Trial Speedups with Real-World Data, Smart Surgical Monitors, and Regulatory Overhaul Begins [July 2nd, 2025]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.